Peptide Therapeutics Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast period 2019-2025. The Global Peptide Therapeutics Industry Report gives an elaborate information about the market size, share and analyzes the complete value chain the report also covers the market dynamics enriching business strategists with quality data about the Peptide Therapeutics market.
This research report categorizes the global Peptide Therapeutics market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.
In this report, we study the peptide-based drugs.In the last several years, global market of Peptide Therapeutics developed rapidly, with an average growth rate of 7.7%. The major factors that are driving the growth of this market are the rising prevalence of metabolic disorders and the increasing pool of cancer patients. The technological advancements, resulting in a significant reduction in the production cost of peptide drugs, is also boosting this market remarkably. In 2017, global revenue of Peptide Therapeutics is nearly 28.5 billion USD; the actual production is about 150 million units.
The classification of Peptide Therapeutics includes Injection, Oral and other, and the proportion of Injection in 2017 is about 74.2%, and the proportion is decreasing trend from 2013 to 2018.
Peptide Therapeutics is widely sales for Cancer, Metabolic Disorders, Central Nervous System and Others. The key application of peptide therapeutics is into cancer mainly used for treating prostrate, pancreatic, ovarian, and breast cancer. and the consumption proportion is about 33.6% in 2017.
In 2017, the global Peptide Therapeutics market size was 28500 million US$ and is forecast to 37400 million US in 2025, growing at a CAGR of 3.5% from 2018. The objectives of this study are to define, segment, and project the size of the Peptide Therapeutics market based on company, product type, application and key regions.
The various contributors involved in the value chain of Peptide Therapeutics include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Peptide Therapeutics include
J & J
Market Size Split by Type
Market Size Split by Application
Central Nervous System
Market size split by Region
Central & South America
Rest of Central & South America
Middle East & Africa
The study objectives of this report are:
To study and analyze the global Peptide Therapeutics market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Peptide Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Peptide Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Peptide Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Peptide Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents - Guidelines
1 Study Coverage
1.1 Peptide Therapeutics Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Peptide Therapeutics Market Size Growth Rate by Type
1.5 Market by Application
1.5.1 Global Peptide Therapeutics Market Size Growth Rate by Application
1.5.3 Metabolic Disorders
1.5.4 Central Nervous System
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Peptide Therapeutics Market Size
2.1.1 Global Peptide Therapeutics Revenue 2016-2025
2.1.2 Global Peptide Therapeutics Sales 2016-2025
2.2 Peptide Therapeutics Growth Rate by Regions
2.2.1 Global Peptide Therapeutics Sales by Regions
2.2.2 Global Peptide Therapeutics Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Peptide Therapeutics Sales by Manufacturers
3.1.1 Peptide Therapeutics Sales by Manufacturers
3.1.2 Peptide Therapeutics Sales Market Share by Manufacturers
3.1.3 Global Peptide Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Peptide Therapeutics Revenue by Manufacturers
3.2.1 Peptide Therapeutics Revenue by Manufacturers (2016-2018)
3.2.2 Peptide Therapeutics Revenue Share by Manufacturers (2016-2018)
3.3 Peptide Therapeutics Price by Manufacturers
3.4 Peptide Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Peptide Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Peptide Therapeutics Product Category
3.4.3 Date of International Manufacturers Enter into Peptide Therapeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Peptide Therapeutics Sales by Type
4.2 Global Peptide Therapeutics Revenue by Type
4.3 Peptide Therapeutics Price by Type
5 Breakdown Data by Application
5.2 Global Peptide Therapeutics Breakdown Data by Application
6 North America
6.1 North America Peptide Therapeutics by Countries
6.1.1 North America Peptide Therapeutics Sales by Countries
6.1.2 North America Peptide Therapeutics Revenue by Countries
6.1.3 United States
6.2 North America Peptide Therapeutics by Type
6.3 North America Peptide Therapeutics by Application
6.4 North America Peptide Therapeutics by Company
7.1 Europe Peptide Therapeutics by Countries
7.1.1 Europe Peptide Therapeutics Sales by Countries
7.1.2 Europe Peptide Therapeutics Revenue by Countries
7.2 Europe Peptide Therapeutics by Type
7.3 Europe Peptide Therapeutics by Application
7.4 Europe Peptide Therapeutics by Company
8 Asia Pacific
8.1 Asia Pacific Peptide Therapeutics by Countries
8.1.1 Asia Pacific Peptide Therapeutics Sales by Countries
8.1.2 Asia Pacific Peptide Therapeutics Revenue by Countries
www.decisiondatabases.com is a online aggregator of market and research database which includes databases, reports and profiles. We have started this portal with a aim to become one stop shop provider for marketing and research data requirements for various sector and country databases.